Difference between revisions of "Part:BBa K5460000"

Line 6: Line 6:
 
             <img src="https://static.igem.wiki/teams/5460/part-registry/r.jpg" alt="图一" style="width: 600px; margin-right: 10px;">
 
             <img src="https://static.igem.wiki/teams/5460/part-registry/r.jpg" alt="图一" style="width: 600px; margin-right: 10px;">
 
         </div>
 
         </div>
         <p>This allows us to easily integrate different promoters into the plasmid system through a simple GoldenGate reaction. Using distinct fluorescent signal channels to report different biomarkers, this system provides the biotechnological foundation for our hardware. <br>Through this reporting system, we tested the response curves of four different biomarkers—uric acid, glucose, tryptophan, and lactate—using three fluorescent proteins: mKate2, sfGFP, and mTagBF2. The data were fitted to Hill equations for analysis:</p>
+
         <p>This allows us to easily incorporate different promoters into this plasmid system through a simple Golden Gate reaction. Different fluorescent signal channels report different biomarkers, providing a biotechnological foundation for our hardware system. Using this reporting system, we tested three different fluorescent proteins—mKate2, sfGFP, and mTagBF2—to report on four different biomarkers: uric acid, glucose, tryptophan, and lactic acid.</p>
 +
<div style="display: flex; justify-content: center; align-items: center;">
 +
    <img src="https://static.igem.wiki/teams/5460/part-registry/uar.png" alt="图2" style="width: 225px; margin-right: 10px;">
 +
            <img src="https://static.igem.wiki/teams/5460/part-registry/glur.png" alt="图3" style="width: 225px; margin-right: 10px;">
 +
            <img src="https://static.igem.wiki/teams/5460/part-registry/laticr.png" alt="图4" style="width: 225px;">
 +
        <img src="https://static.igem.wiki/teams/5460/part-registry/trpr.png" alt="图4" style="width: 225px;">
 +
        </div>
 +
 
 +
<p>Through experimental testing, we successfully obtained the signal intensities corresponding to different concentrations of these biomarkers, validating the feasibility of our system.</p>
 +
<div style="display: flex; justify-content: center; align-items: center;">
 +
    <img src="https://static.igem.wiki/teams/5460/part-registry/ua-zhutu.jpg" alt="图2" style="width: 230px; margin-right: 10px;">
 +
            <img src="https://static.igem.wiki/teams/5460/part-registry/glu-zhutu.jpg" alt="图3" style="width: 230px; margin-right: 10px;">
 +
            <img src="https://static.igem.wiki/teams/5460/part-registry/latic-zhutu.jpg" alt="图4" style="width: 230px;">
 +
        <img src="https://static.igem.wiki/teams/5460/part-registry/trp-zhutu.jpg" alt="图4" style="width: 230px;">
 +
        </div>
 +
 
 +
<p>Subsequently, we generated response curves from these data and performed Hill equation fitting.</p>
 
         <div style="display: flex; justify-content: center; align-items: center;">
 
         <div style="display: flex; justify-content: center; align-items: center;">
 
     <img src="https://static.igem.wiki/teams/5460/part-registry/glu-curve.jpg" alt="图2" style="width: 225px; margin-right: 10px;">
 
     <img src="https://static.igem.wiki/teams/5460/part-registry/glu-curve.jpg" alt="图2" style="width: 225px; margin-right: 10px;">
Line 13: Line 29:
 
         <img src="https://static.igem.wiki/teams/5460/part-registry/ua-curve.jpg" alt="图4" style="width: 225px;">
 
         <img src="https://static.igem.wiki/teams/5460/part-registry/ua-curve.jpg" alt="图4" style="width: 225px;">
 
         </div>
 
         </div>
       <p>In the future, this system can be adapted to detect other biomarkers by replacing the plasmid accordingly. Additionally, we have developed a hardware system designed to work in conjunction with this detection system. For more details, please refer to our <strong>Hardware</strong>page.</p>
+
       <p>In the future, this system can be adapted to detect other biomarkers by replacing the plasmid accordingly. Additionally, we have developed a hardware system designed to work in conjunction with this detection system. For more details, please refer to our <strong>Hardware</strong> page.</p>
 
     </div>
 
     </div>
 
</body>
 
</body>

Revision as of 01:08, 2 October 2024

Reporting assay with Standardized Interfaces
This part serves as a reporting module (R module) of our system. In some cases, this plasmid needs to be used in conjunction with our A module. To align with our hardware system for simultaneous multi-biomarker detection, we require various biomarker-sensitive promoters and different fluorescent proteins to avoid signal cross-talk.
We optimized and improved the plasmid system by introducing a GoldenGate interface at key sites within this module. Specifically, we designed a standardized GoldenGate interface at the positions of the promoter and the fluorescent protein.

图一

This allows us to easily incorporate different promoters into this plasmid system through a simple Golden Gate reaction. Different fluorescent signal channels report different biomarkers, providing a biotechnological foundation for our hardware system. Using this reporting system, we tested three different fluorescent proteins—mKate2, sfGFP, and mTagBF2—to report on four different biomarkers: uric acid, glucose, tryptophan, and lactic acid.

图2 图3 图4 图4

Through experimental testing, we successfully obtained the signal intensities corresponding to different concentrations of these biomarkers, validating the feasibility of our system.

图2 图3 图4 图4

Subsequently, we generated response curves from these data and performed Hill equation fitting.

图2 图3 图4 图4

In the future, this system can be adapted to detect other biomarkers by replacing the plasmid accordingly. Additionally, we have developed a hardware system designed to work in conjunction with this detection system. For more details, please refer to our Hardware page.


Sequence and Features


Assembly Compatibility:
  • 10
    INCOMPATIBLE WITH RFC[10]
    Illegal PstI site found at 346
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal PstI site found at 346
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal PstI site found at 346
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal PstI site found at 346
  • 1000
    COMPATIBLE WITH RFC[1000]